Secretory breast carcinomas with ETV6-NTRK3 fusion gene belong to the basal-like carcinoma spectrum

Modern Pathology

Volumn 22, Issue 2, 2009, Pages 291-298

  Laé, Marick ^a   Fréneaux, Paul ^a   Sastre Garau, Xavier ^a   Chouchane, Olfa ^a   Sigal Zafrani, Brigitte ^a   Vincent Salomon, Anne ^a  

^a INSTITUT CURIE   (France)

Author keywords

Basal cytokeratins; Basal like carcinoma; Breast; ETV6 NTRK3; Secretory breast carcinoma; Translocation

Indexed keywords

ANTIBODY; CYTOKERATIN; CYTOKERATIN 18; CYTOKERATIN 8; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ERBIUM; NEUROTROPHIN 3 TYROSINE KINASE PROTEIN; PHOSPHORYLASE PHOSPHATASE; PROTEIN P63; PROTEIN SUBUNIT; PROTEIN TYROSINE KINASE; PS100; SMOOTH MUSCLE ACTIN; STEM CELL FACTOR; TRANSCRIPTION FACTOR ETV6; UNCLASSIFIED DRUG; UVOMORULIN; VIMENTIN;

ADULT; ARTICLE; BASAL CELL CARCINOMA; BREAST CARCINOMA; CLINICAL ARTICLE; CLINICAL FEATURE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE FUSION; GENE REARRANGEMENT; GENE TRANSLOCATION; GENETIC SIMILARITY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; INVASIVE PROCEDURE; KINETOSOME; MUTATION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SECRETORY BREAST CARCINOMA; SPECTRUM;

ADULT; BREAST NEOPLASMS; CARCINOMA; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOTYPE; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; IN SITU HYBRIDIZATION, FLUORESCENCE; MIDDLE AGED; NEOPLASM INVASIVENESS; ONCOGENE PROTEINS, FUSION; PHENOTYPE; TRANSLOCATION, GENETIC; TUMOR MARKERS, BIOLOGICAL;

EID: 59149096465     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2008.184     Document Type: Article

References (25)

1. Tavassoli FA, Devilee P, (eds). World Health Organization Classification of Tumors Pathology and Genetics of Tumors of the Breast and Female Genital Organs. IARC Press: Lyon, 2003.
2. McDivitt RW, Stewart FW. Breast carcinoma in children. JAMA 1966;195:388-390.
3. Rosen PP, Cranor ML. Secretory carcinoma of the breast. Arch Pathol Lab Med 1991;115:141-144.
4. Oberman HA. Secretory carcinoma of the breast in adults. Am J Surg Pathol 1980;4:465-470.
5. Tognon C, Knezevich SR, Huntsman D, et al. Expression of the ETV6-NTRK3 gene fusion as a primary event in human SBC. Cancer Cell 2002;2:367-376.
6. Knezevich SR, McFadden DE, Tao W, et al. A novel ETV6-NTRK3 gene fusion in congenital fibrosarcoma. Nat Genet 1998;18:184-187.
7. Knezevich SR, Garnett MJ, Pysher TJ, et al. ETV6-NTRK3 gene fusions and trisomy 11 establish a histogenetic link between mesoblastic nephroma and congenital fibrosarcoma. Cancer Res 1998;58:5046-5048.
8. Lannon CL, Sorensen PH. ETV6-NTRK3: a chimeric protein tyrosine kinase with transformation activity in multiple cell lineages. Semin Cancer Biol 2005;15:215-223.
9. Perou CM, Sørlie T, Eisen MB, et al. Molecular portraits of human breast tumours. Nature 2000;406:747-752.
10. Sørlie T, Perou CM, Tibshirani R, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 2001;98:10869-10874.
11. Nielsen TO, Hsu FD, Jensen K, et al. Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clin Cancer Res 2004;10:5367-5374.
12. Carey LA, Perou C, Livasy CA. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 2006;295:2492-2502.
13. Vincent-Salomon A, Mac Grogan G, Couturier J, et al. Calibration of immunohistochemistry for assessment of HER2 in breast cancer: results of the French multicentric GEFPICS study. Histopathology 2003;42:337-347.
14. Lamovec J, Bracko M. Secretory carcinoma of the breast: light microscopical, immunohistochemical and flow cytometric study. Mod Pathol 1994;7:475-479.
15. Botta G, Fessia L, Ghiringhello B. Juvenile milk protein secreting carcinoma. Virchows Arch A Pathol Anat Histol 1982;395:145-152.
16. Jacquemier J, Padovani L, Rabayrol L, et al. Typical medullary breast carcinomas have a basal/myoepithelial phenotype. J Pathol 2005;207:260-268.
17. Reis-Filho JS, Milanezi F, Steele D, et al. Metaplastic breast carcinomas are basal-like tumours. Histopathology 2006;49:10-21.
18. Azoulay S, Laé M, Fréneaux P, et al. KIT is highly expressed in adenoid cystic carcinoma of the breast, a basal-like carcinoma associated with a favorable outcome. Mod Pathol 2005;18:1623-1631.
19. Bryan BB, Schnitt SJ, Collins LC. Ductal carcinoma in situ with basal-like phenotype: a possible precursor to invasive basal-like breast cancer. Mod Pathol 2006;19:617-621.
20. Makretsov N, He M, Hayes M, et al. A fluorescence in situ hybridization study of ETV6-NTRK3 fusion gene in secretory breast carcinoma. Genes Chromosomes Cancer 2004;40:152-157.
21. Arce C, Cortes-Padilla D, Huntsman DG, et al. Secretory carcinoma of the breast containing the ETV6-NTRK3 fusion gene in a male: case report and review of the literature. World J Surg Oncol 2005;3:35.
22. Herz H, Cooke B, Goldstein D. Metastatic secretory breast cancer. Non-responsiveness to chemotherapy: case report and review of the literature. Ann Oncol 2000;11:1343-1347.
23. Maitra A, Tavassoli FA, Albores-Saavedra J, et al. Molecular abnormalities associated with secretory carcinomas of the breast. Hum Pathol 1999;30:1435-1440.
24. McCahon E, Sorensen PH, Davis JH, et al. Non-resectable congenital tumors with the ETV6-NTRK3 gene fusion are highly responsive to chemotherapy. Med Pediatr Oncol 2003;40:288-292.
25. Li Z, Tognon CE, Godinho FJ, et al. ETV6-NTRK3 fusion oncogene initiates breast cancer from committed mammary progenitors via activation of AP1 complex. Cancer Cell 2007;12:542-558.